| Biotechnology Industry | Healthcare Sector | Mr. Hong Xu CEO | JPX Exchange | - ISIN |
| CN Country | 200 Employees | - Last Dividend | - Last Split | - IPO Date |
Broncus Holding Corporation is a pioneering medical device company dedicated to advancing the field of interventional pulmonology. Established in 2012 and headquartered in Hangzhou, China, the company engages in the development and distribution of innovative products across Mainland China, the European Union, the United States, and other international markets. Its portfolio spans navigation and treatment products for lung diseases, as well as diagnostic tools that cater to the needs of the pulmonology community. By focusing on breakthrough technologies, Broncus aims to improve patient outcomes and enhance the precision and effectiveness of lung disease management.